Neugebauer, Sina
Griesinger, Frank
Dippel, Sabine
Heidenreich, Stephanie
Gruber, Nina
Chruscz, Detlef
Lempfert, Sebastian
Kaskel, Peter
Funding for this research was provided by:
MSD SHARP & DOHME, Haar, Germany (#1659 OSTIC 2021-ms-0264, #1659 OSTIC 2021-ms-0264, #1659 OSTIC 2021-ms-0264, #1659 OSTIC 2021-ms-0264, #1659 OSTIC 2021-ms-0264, #1659 OSTIC 2021-ms-0264, #1659 OSTIC 2021-ms-0264)
Article History
Received: 26 February 2021
Accepted: 8 April 2022
First Online: 28 June 2022
Declarations
:
: Not applicable as anonymized data were used: Anonymized SHI data were used for this research and presented in aggregated form only. The use of such data is not subject to ethics committee approval in Germany. All InGef studies need approval from the internal InGef (formerly HRI) Scientific Research Group, which considers both ethical and scientific aspects of the intended study(15), and the study was cleared accordingly.The InGef database is not freely accessible, access requires a scientific request and an approval of the data donating statutory health insurance.
: Not applicable.
: Sina Neugebauer is employee of MSD SHARP & DOHME GMBH, Munich<b>,</b> Germany.Frank Griesinger has disclosures from the following companies: Abbvie, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Chugai, Lilly, Medac, Merck, MSD, Novartis, Pfizer, Roche and Takeda.Sabine Dippel is employee of Organon GmbH, Luzern, Switzerland. At the time of the manuscript development Sabine Dippel was employed at MSD MERCK SHARP & DOHME AG, Luzern, Switzerland. At the time of study conduct, Sabine Dippel was employed at MSD SHARP & DOHME GMBH, Haar, Germany.Stephanie Heidenreich is employee of MSD SHARP & DOHME GMBH, Munich, Germany.Nina Gruber is employee of MSD SHARP & DOHME GMBH, Munich, Germany.Detlef Chruscz is employee of CONVEMA, which was retained as paid analyst by MSD SHARP & DOHME GMBH to conduct this research.Sebastian Lempfert is managing director of HCSL Healthcare Consulting e.K., which was retained as paid consultant by MSD SHARP & DOHME GMBH.At the time the study was designed and executed and the manuscript developed and finalized, Peter Kaskel was employee of MSD SHARP & DOHME GMBH, Haar, Germany. Peter Kaskel has ownership interests with MERCK & CO., INC., Kenilworth, NJ, USA.